BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31605195)

  • 1. Centralization tendencies of retroperitoneal lymph node dissection for testicular cancer in Germany? A total population-based analysis from 2006 to 2015.
    Groeben C; Koch R; Nestler T; Kraywinkel K; Borkowetz A; Wenzel S; Baunacke M; Thomas C; Huber J
    World J Urol; 2020 Jul; 38(7):1765-1772. PubMed ID: 31605195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of robotics for retroperitoneal lymph-node dissection in pediatric and non-pediatric hospitals.
    Brown CT; Sebastião YV; Zann A; McLeod DJ; DaJusta D
    J Robot Surg; 2020 Dec; 14(6):865-870. PubMed ID: 32200542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011).
    Hugen CM; Hu B; Jeldres C; Burton C; Nichols CR; Porter CR; Daneshmand S
    Urol Oncol; 2016 Nov; 34(11):487.e7-487.e11. PubMed ID: 27372281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate.
    Foster R; Bihrle R
    Cancer Control; 2002; 9(4):277-83. PubMed ID: 12228753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
    Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
    J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary retroperitoneal lymph node dissection (RPLND) for testis cancer in the UK - a national study.
    Wells H; Hayes MC; O'Brien T; Fowler S
    BJU Int; 2017 Jan; 119(1):91-99. PubMed ID: 27353395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor.
    Kim P; Syan-Bhanvadia S; Djaladat H; Faber K; Tadros NN; Nichols C; Daneshmand S
    Urology; 2012 Oct; 80(4):941-5. PubMed ID: 22951007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
    Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
    Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
    J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals.
    Blok JM; Meijer RP; van der Poel HG; Bex A; van Vooren J; van Urk JJ; Horenblas S; Bosch JLHR
    World J Urol; 2021 Mar; 39(3):839-846. PubMed ID: 32372160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Harris KT; Gorin MA; Ball MW; Pierorazio PM; Allaf ME
    BJU Int; 2015 Dec; 116(6):920-3. PubMed ID: 25781349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.
    Hermans TJ; Fransen van de Putte EE; Fossion LM; Werkhoven EV; Verhoeven RH; van Rhijn BW; Horenblas S
    Urol Oncol; 2016 Dec; 34(12):532.e7-532.e12. PubMed ID: 27491835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.